Retatrutide
Batch #010006 · Research use only.
Supreme Peptides research compound
Retatrutide is a novel multi-agonist peptide studied for its ability to simultaneously engage multiple metabolic hormone receptors involved in appetite regulation, glucose metabolism, and energy expenditure. In research settings, it has gained significant attention for its broad, integrative approach to metabolic signaling compared to single-pathway peptides.
Product overview
Retatrutide is a research-grade synthetic peptide engineered to activate GLP-1, GIP, and glucagon receptors, creating a unique tri-agonist profile. Preclinical and clinical research associate Retatrutide with enhanced metabolic efficiency, appetite modulation, and increased energy utilization. Its multi-receptor mechanism makes it a valuable tool for studying complex metabolic conditions and adaptive weight-management pathways.
Key research features
Multi-pathway metabolic signaling:
Retatrutide is widely studied for its ability to simultaneously influence satiety, insulin signaling, and energy expenditure. Research models explore how this tri-agonist activity may produce more comprehensive metabolic effects than single-receptor compounds.
Appetite and weight-regulation research:
Studies suggest Retatrutide may significantly impact hunger signaling and caloric intake through central and peripheral mechanisms, making it highly relevant in experimental research focused on obesity and body-weight regulation.
Energy expenditure and glucose metabolism:
Research indicates Retatrutide may enhance energy utilization and support glucose homeostasis by activating glucagon-related pathways alongside incretin signaling, contributing to its interest in metabolic health and endurance-related studies.
Retatrutide Suggested Use:
Typical Dose: 3.5–12 mg per week
Route: Subcutaneous
Frequency: once per week or 2 times per week ( Weekly dose broken into 2 shots)
Duration: As recommended by a healthcare professional